CD81 通过阻断 CD274/PD-L1 的选择性自噬降解驱动放射抵抗性胶质母细胞瘤的免疫逃逸
CD81 drives immune evasion in radioresistant glioblastoma by blocking selective autophagic degradation of CD274/PD-L1.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:The glioblastoma multiforme tumor site promotes the commitment of tumor-infiltrating lymphocytes to the T(H)17 lineage in humans.
The glioblastoma multiforme tumor site promotes the commitment of tumor-infiltrating lymphocytes to the T(H)17 lineage in humans.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
尽管多形性胶质母细胞瘤(GBM)并非始终是“冷肿瘤”,但检查点抑制在GBM中基本失败。为了研究导致GBM对内源性或治疗增强的适应性免疫应答产生抵抗的T细胞内在特性,我们从九例未经治疗的GBM患者的外周血、正常外观脑组织和肿瘤床中分选了CD4+和CD8+T细胞。对这些不同区域高度纯化的T细胞群体进行bulk RNA测序,以获得肿瘤浸润T细胞(TILs)的深度转录组。虽然CD8+TILs的转录组提示它们部分锁定于功能障碍状态,但CD4+TILs显示出对17型辅助性T细胞(TH17)谱系的强烈倾向,这一发现在另外四例GBM病例中通过流式细胞术得到证实。因此,我们的研究表明,GBM中的脑肿瘤环境可能指导浸润性辅助性T细胞的TH17定向。CD4+TILs的这些特性是否促进促肿瘤微环境,从而可能成为辅助性抗TH17细胞干预的靶点,需要进一步研究。
Although glioblastoma multiforme (GBM) is not an invariably cold tumor, checkpoint inhibition has largely failed in GBM. In order to investigate T cell-intrinsic properties that contribute to the resistance of GBM to endogenous or therapeutically enhanced adaptive immune responses, we sorted CD4 + and CD8 + T cells from the peripheral blood, normal-appearing brain tissue, and tumor bed of nine treatment-naive patients with GBM.
Bulk RNA sequencing of highly pure T cell populations from these different compartments was used to obtain deep transcriptomes of tumor-infiltrating T cells (TILs). While the transcriptome of CD8 + TILs suggested that they were partly locked in a dysfunctional state, CD4 + TILs showed a robust commitment to the type 17 T helper cell (T H 17) lineage, which was corroborated by flow cytometry in four additional GBM cases.
Therefore, our study illustrates that the brain tumor environment in GBM might instruct T H 17 commitment of infiltrating T helper cells. Whether these properties of CD4 + TILs facilitate a tumor-promoting milieu and thus could be a target for adjuvant anti-T H 17 cell interventions needs to be further investigated.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。